Heme oxygenase-1 as a target for the design of gene and pharmaceutical therapies for autoimmune diseases.

Saved in:
Bibliographic Details
Title: Heme oxygenase-1 as a target for the design of gene and pharmaceutical therapies for autoimmune diseases.
Authors: Mackern-Oberti JP, Riquelme SA, Llanos C, Schmidt CB, Simon T, Anegon I, Jara E, Riedel CA, Bueno SM, Kalergis AM; Millennium Institute on Immunology and Immunotherapy Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Departamento de Inmunología Clínica y Reumatología, Facultad de Medicina, Pontificia Universidad Católica de Chile. Av Portugal #49, Santiago, Chile. akalergis@bio.puc.cl.
Source: Current gene therapy [Curr Gene Ther] 2014; Vol. 14 (3), pp. 218-35.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
Journal Info: Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 101125446 Publication Model: Print Cited Medium: Internet ISSN: 1875-5631 (Electronic) Linking ISSN: 15665232 NLM ISO Abbreviation: Curr Gene Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1875-5631
DOI:10.2174/1566523214666140424150308